• 2022-10-02
    Last Updated
  • 200
    Pages

Biologic Therapeutic Drug Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

The Biologic Therapeutic Drug Market accounted for US$ XX Million/Billion in the year 2022 and is expected to grow at a CAGR of XX% during the forecast period 2021 - 2030, to account for US$ XX Million/Billion in the year 2030.

Global Biologic Therapeutic Drug Market is segmented by region into North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America. The North America regional market is expected to grow with CAGR of XX.X% and reach US$ XX Million/Billion 2015 from US$ XX Million/Billion in 2022.

The key players profiled in the Biologic Therapeutic Drug Market research study includes top:

Aurobindo Pharma Ltd., Concord Biotech, GlaxoSmithKline Plc., H. Lundbeck A/S, Novartis Global, Retractable Technologies, Inc., Smith Medical, AstraZeneca, Pfizer Inc., Merck and Co. Inc.

Segment by Type
Monoclonal Antibodies
Therapeutic Proteins
Vaccines

Segment by Application
Clinical Medicine
Laboratory
Others

Since, the key findings in the Biologic Therapeutic Drug Market research reports highlight crucial progressive industry trends, it allows the companies across the value chain to develop effective long-term strategies. The clients get to understand a clear picture of the competitors and can develop strategies and modify business expansion plans accordingly. The Biologic Therapeutic Drug Market research reports cover thousands of global players that based on several parameters, such as company revenue, product portfolio, and geographic presence.

marketreports.info adheres to the codes of practice of the Market Research Society and Strategic and Competitive Intelligence Professionals. The following methodology has been followed for the collection and analysis of data presented in this report:

Coverage:

The objective of updating “marketreports.info” coverage is to ensure that it represents the most up-to-date vision of the industry possible. The estimated revenues of all major companies, including private and governmental, are gathered and used to prioritize coverage. Companies which are making the news, or which are of particular interest due to their innovative approach, are prioritized.

Secondary Research:

The Biologic Therapeutic Drug research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information relating to each Biologic Therapeutic Drug Market. The secondary research sources that are typically referred to include, but are not limited to:

  • Biologic Therapeutic Drug related Company Websites, Annual Reports, Financial Reports, Broker Reports and Investor Presentations
  • Biologic Therapeutic Drug Industry Trade Journals and Other Literature
  • Biologic Therapeutic Drug related National Government Documents, Statistical Databases and Market Reports
  • Biologic Therapeutic Drug related News Articles, Press Releases and Web-Casts Specific to the Companies Operating in the Market

NOTE: All the financials considered in Company Profile’s section have been standardized to US$. This has been achieved after converting the financials (for those not in US$) with respective currency exchange rates of the particular year.

Primary Research:

“marketreports.info” conducts hundreds of primary interviews a year with industry participants and commentators in order to validate its data and analysis. A typical Biologic Therapeutic Drug research interview fulfils the following functions:

  • Provides First-Hand Information on Biologic Therapeutic Drug Market Size, Market Trends, Growth Trends, Competitive Landscape and Future Outlook
  • Biologic Therapeutic Drug Market Validates and Strengthens Secondary Research Findings
  • Biologic Therapeutic Drug Market Further Develops the Analysis Team’s Expertise and Market Understanding

Primary research involves email interactions and telephone interviews for each Biologic Therapeutic Drug market, category, segment and sub -segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  1. Biologic Therapeutic Drug Industry Participants: VPs, Business Development Managers, Market Intelligence Managers and National Sales Managers
  2. Biologic Therapeutic Drug Outside Experts: Valuation Experts, Research Analysts and Key Opinion Leaders Specializing in the Industry
Chapter 1 Global Biologic Therapeutic Drug Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Biologic Therapeutic Drug Market
1.4 Restraints for Biologic Therapeutic Drug Market
1.5 Opportunities for Biologic Therapeutic Drug Market
1.6 Trends for Biologic Therapeutic Drug Market
1.7 COVID-19 Impact Assessment on Biologic Therapeutic Drug Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Biologic Therapeutic Drug Market Overview

2.1 Global Biologic Therapeutic Drug Market by Product Type
2.1.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Biologic Therapeutic Drug Market by End User
2.2.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Biologic Therapeutic Drug Market by Region
2.3.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Biologic Therapeutic Drug Market Outlook (2013-2029)
2.4.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
2.8.2 Global Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
2.9 Global Biologic Therapeutic Drug Market Share Comparison (2013-2029)
2.9.1 Global Biologic Therapeutic Drug Market Share by Region
2.9.2 Global Biologic Therapeutic Drug Market Share by Product Type
2.9.3 Global Biologic Therapeutic Drug Market Share by End User

Chapter 3 North America Biologic Therapeutic Drug Market Overview

3.1 North America Biologic Therapeutic Drug Market by Product Type
3.1.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Biologic Therapeutic Drug Market by End User
3.2.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Biologic Therapeutic Drug Market by Region
3.3.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Biologic Therapeutic Drug Market Outlook (2013-2029)
3.4.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
3.8.2 North America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
3.9 North America Biologic Therapeutic Drug Market Share Comparison (2013-2029)
3.9.1 North America Biologic Therapeutic Drug Market Share by Region
3.9.2 North America Biologic Therapeutic Drug Market Share by Product Type
3.9.3 North America Biologic Therapeutic Drug Market Share by End User

Chapter 4 Europe Biologic Therapeutic Drug Market Overview

4.1 Europe Biologic Therapeutic Drug Market by Product Type
4.1.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Biologic Therapeutic Drug Market by End User
4.2.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Biologic Therapeutic Drug Market by Region
4.3.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Biologic Therapeutic Drug Market Outlook (2013-2029)
4.4.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
4.8.2 Europe Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
4.9 Europe Biologic Therapeutic Drug Market Share Comparison (2013-2029)
4.9.1 Europe Biologic Therapeutic Drug Market Share by Region
4.9.2 Europe Biologic Therapeutic Drug Market Share by Product Type
4.9.3 Europe Biologic Therapeutic Drug Market Share by End User

Chapter 5 Asia Pacific Biologic Therapeutic Drug Market Overview

5.1 Asia Pacific Biologic Therapeutic Drug Market by Product Type
5.1.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Biologic Therapeutic Drug Market by End User
5.2.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Biologic Therapeutic Drug Market by Region
5.3.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Biologic Therapeutic Drug Market Outlook (2013-2029)
5.4.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Biologic Therapeutic Drug Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Biologic Therapeutic Drug Market Share by Region
5.9.2 Asia Pacific Biologic Therapeutic Drug Market Share by Product Type
5.9.3 Asia Pacific Biologic Therapeutic Drug Market Share by End User

Chapter 6 South America Biologic Therapeutic Drug Market Overview

6.1 South America Biologic Therapeutic Drug Market by Product Type
6.1.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Biologic Therapeutic Drug Market by End User
6.2.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Biologic Therapeutic Drug Market by Region
6.3.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Biologic Therapeutic Drug Market Outlook (2013-2029)
6.4.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
6.8.2 South America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
6.9 South America Biologic Therapeutic Drug Market Share Comparison 2013-2029
6.9.1 South America Biologic Therapeutic Drug Market Share by Region
6.9.2 South America Biologic Therapeutic Drug Market Share by Product Type
6.9.3 South America Biologic Therapeutic Drug Market Share by End User

Chapter 7 MEA Biologic Therapeutic Drug Market Overview

7.1 MEA Biologic Therapeutic Drug Market by Product Type
7.1.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Biologic Therapeutic Drug Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Biologic Therapeutic Drug Market by End User
7.2.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Biologic Therapeutic Drug Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Biologic Therapeutic Drug Market by Region
7.3.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Biologic Therapeutic Drug Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Biologic Therapeutic Drug Market Outlook (2013-2029)
7.4.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Biologic Therapeutic Drug Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Biologic Therapeutic Drug Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Region
7.8.2 MEA Biologic Therapeutic Drug Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Biologic Therapeutic Drug Market Y-o-Y Growth Rate by End User
7.9 MEA Biologic Therapeutic Drug Market Share Comparison (2013-2029)
7.9.1 MEA Biologic Therapeutic Drug Market Share by Region
7.9.2 MEA Biologic Therapeutic Drug Market Share by Product Type
7.9.3 MEA Biologic Therapeutic Drug Market Share by End User

Chapter 8 Global Biologic Therapeutic Drug Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800